Cargando…
Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a common head and neck malignancy. The incidence of NPC is higher in Southern China and Southeast Asia compared with Western countries. Given its high radiosensitivity, the standard treatment for NPC is radiotherapy. However, radioresistance remains a serious obstac...
Autores principales: | Chen, Wei, Hu, Guo-Hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chinese Anti-Cancer Association
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383846/ https://www.ncbi.nlm.nih.gov/pubmed/25859408 http://dx.doi.org/10.7497/j.issn.2095-3941.2014.0015 |
Ejemplares similares
-
Radiosensitivity-Related Genes and Clinical Characteristics of Nasopharyngeal Carcinoma
por: Dai, Yongmei, et al.
Publicado: (2020) -
MiR‐24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1
por: Kang, Min, et al.
Publicado: (2016) -
Radiosensitivity enhancement by combined treatment of nimotuzumab and celecoxib on nasopharyngeal carcinoma cells
por: Huang, Jianfeng, et al.
Publicado: (2018) -
Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
por: Chen, Hao, et al.
Publicado: (2021) -
Correction to: Inhibition of PAD4 enhances radiosensitivity and inhibits aggressive phenotypes of nasopharyngeal carcinoma cells
por: Chen, Hao, et al.
Publicado: (2021)